<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-05-01" modified="2018-01-31" version="224">
<accession>P25445</accession>
<accession>A9UJX4</accession>
<accession>B6VNV4</accession>
<accession>Q14292</accession>
<accession>Q14293</accession>
<accession>Q14294</accession>
<accession>Q14295</accession>
<accession>Q16652</accession>
<accession>Q5T9P1</accession>
<accession>Q5T9P2</accession>
<accession>Q5T9P3</accession>
<accession>Q6SSE9</accession>
<name>TNR6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tumor necrosis factor receptor superfamily member 6</fullName>
</recommendedName>
<alternativeName>
<fullName>Apo-1 antigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Apoptosis-mediating surface antigen FAS</fullName>
</alternativeName>
<alternativeName>
<fullName>FASLG receptor</fullName>
</alternativeName>
<cdAntigenName>CD95</cdAntigenName>
</protein>
<gene>
<name type="primary">FAS</name>
<name type="synonym">APT1</name>
<name type="synonym">FAS1</name>
<name type="synonym">TNFRSF6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="66" first="233" last="243">
<title>The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.</title>
<authorList>
<person name="Itoh N."/>
<person name="Yonehara S."/>
<person name="Ishii A."/>
<person name="Yonehara M."/>
<person name="Mizushima S."/>
<person name="Sameshima M."/>
<person name="Hase A."/>
<person name="Seto Y."/>
<person name="Nagata S."/>
</authorList>
<dbReference type="PubMed" id="1713127"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90614-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="10709" last="10715">
<title>Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.</title>
<authorList>
<person name="Oehm A."/>
<person name="Behrmann I."/>
<person name="Falk W."/>
<person name="Pawlita M."/>
<person name="Maier G."/>
<person name="Klas C."/>
<person name="Li-Weber M."/>
<person name="Richards S."/>
<person name="Dhein J."/>
<person name="Trauth B.C."/>
<person name="Ponstingl H."/>
<person name="Krammer P.H."/>
</authorList>
<dbReference type="PubMed" id="1375228"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 226-240; 269-291 AND 321-335</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Biochem. J." volume="310" first="957" last="963">
<title>Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.</title>
<authorList>
<person name="Liu C."/>
<person name="Cheng J."/>
<person name="Mountz J.D."/>
</authorList>
<dbReference type="PubMed" id="7575433"/>
<dbReference type="DOI" id="10.1042/bj3100957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 6)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="J. Immunol." volume="154" first="2706" last="2713">
<title>Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.</title>
<authorList>
<person name="Cascino I."/>
<person name="Fiucci G."/>
<person name="Papoff G."/>
<person name="Ruberti G."/>
</authorList>
<dbReference type="PubMed" id="7533181"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 6)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="J. Immunol." volume="156" first="13" last="17">
<title>Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.</title>
<authorList>
<person name="Cascino I."/>
<person name="Papoff G."/>
<person name="De Maria R."/>
<person name="Testi R."/>
<person name="Ruberti G."/>
</authorList>
<dbReference type="PubMed" id="8598453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="J. Immunol." volume="156" first="4622" last="4630">
<title>An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.</title>
<authorList>
<person name="Papoff G."/>
<person name="Cascino I."/>
<person name="Eramo A."/>
<person name="Starace G."/>
<person name="Lynch D.H."/>
<person name="Ruberti G."/>
</authorList>
<dbReference type="PubMed" id="8648105"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Immunobiology" volume="212" first="73" last="83">
<title>Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.</title>
<authorList>
<person name="Del-Rey M.J."/>
<person name="Manzanares J."/>
<person name="Bosque A."/>
<person name="Aguilo J.I."/>
<person name="Gomez-Rial J."/>
<person name="Roldan E."/>
<person name="Serrano A."/>
<person name="Anel A."/>
<person name="Paz-Artal E."/>
<person name="Allende L.M."/>
</authorList>
<dbReference type="PubMed" id="17336828"/>
<dbReference type="DOI" id="10.1016/j.imbio.2006.12.003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALPS1A SER-262</scope>
</reference>
<reference key="8">
<citation type="submission" date="1995-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Schaetzlein C.E."/>
<person name="Poehlmann R."/>
<person name="Philippsen P."/>
<person name="Eibel H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Peripheral blood lymphocyte</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2008-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="De La Calle-Martin O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="11">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS THR-16; ILE-122 AND ILE-305</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Cell" volume="81" first="513" last="523">
<title>RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.</title>
<authorList>
<person name="Stanger B.Z."/>
<person name="Leder P."/>
<person name="Lee T.-H."/>
<person name="Kim E."/>
<person name="Seed B."/>
</authorList>
<dbReference type="PubMed" id="7538908"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90072-1"/>
</citation>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="32461" last="32468">
<title>F1Aalpha, a death receptor-binding protein homologous to the Caenorhabditis elegans sex-determining protein, FEM-1, is a caspase substrate that mediates apoptosis.</title>
<authorList>
<person name="Chan S.-L."/>
<person name="Tan K.-O."/>
<person name="Zhang L."/>
<person name="Yee K.S.Y."/>
<person name="Ronca F."/>
<person name="Chan M.-Y."/>
<person name="Yu V.C."/>
</authorList>
<dbReference type="PubMed" id="10542291"/>
<dbReference type="DOI" id="10.1074/jbc.274.45.32461"/>
</citation>
<scope>INTERACTION WITH FEM1B</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="12667" last="12672">
<title>LFG: an anti-apoptotic gene that provides protection from fas-mediated cell death.</title>
<authorList>
<person name="Somia N.V."/>
<person name="Schmitt M.J."/>
<person name="Vetter D.E."/>
<person name="Van Antwerp D."/>
<person name="Heinemann S.F."/>
<person name="Verma I.M."/>
</authorList>
<dbReference type="PubMed" id="10535980"/>
<dbReference type="DOI" id="10.1073/pnas.96.22.12667"/>
</citation>
<scope>INTERACTION WITH FAIM2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R8.1" last="R8.16">
<title>An unappreciated role for RNA surveillance.</title>
<authorList>
<person name="Hillman R.T."/>
<person name="Green R.E."/>
<person name="Brenner S.E."/>
</authorList>
<dbReference type="PubMed" id="14759258"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-2-r8"/>
</citation>
<scope>SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="52106" last="52116">
<title>A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway.</title>
<authorList>
<person name="Li Q."/>
<person name="Ching A.K.-K."/>
<person name="Chan B.C.-L."/>
<person name="Chow S.K.-Y."/>
<person name="Lim P.-L."/>
<person name="Ho T.C.-Y."/>
<person name="Ip W.-K."/>
<person name="Wong C.-K."/>
<person name="Lam C.W.-K."/>
<person name="Lee K.K.-H."/>
<person name="Chan J.Y.-H."/>
<person name="Chui Y.-L."/>
</authorList>
<dbReference type="PubMed" id="15465831"/>
<dbReference type="DOI" id="10.1074/jbc.M408678200"/>
</citation>
<scope>INTERACTION WITH BABAM2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-118</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="87" first="873" last="881">
<title>Whole-exome-sequencing-based discovery of human FADD deficiency.</title>
<authorList>
<person name="Bolze A."/>
<person name="Byun M."/>
<person name="McDonald D."/>
<person name="Morgan N.V."/>
<person name="Abhyankar A."/>
<person name="Premkumar L."/>
<person name="Puel A."/>
<person name="Bacon C.M."/>
<person name="Rieux-Laucat F."/>
<person name="Pang K."/>
<person name="Britland A."/>
<person name="Abel L."/>
<person name="Cant A."/>
<person name="Maher E.R."/>
<person name="Riedl S.J."/>
<person name="Hambleton S."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="21109225"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2010.10.028"/>
</citation>
<scope>INTERACTION WITH FADD</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="1" last="17">
<title>Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD.</title>
<authorList>
<person name="Halim A."/>
<person name="Nilsson J."/>
<person name="Ruetschi U."/>
<person name="Hesse C."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="22171320"/>
<dbReference type="DOI" id="10.1074/mcp.M111.013649"/>
</citation>
<scope>GLYCOSYLATION AT THR-28</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="1996" name="Nature" volume="384" first="638" last="641">
<title>NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.</title>
<authorList>
<person name="Huang B."/>
<person name="Eberstadt M."/>
<person name="Olejniczak E.T."/>
<person name="Meadows R.P."/>
<person name="Fesik S.W."/>
</authorList>
<dbReference type="PubMed" id="8967952"/>
<dbReference type="DOI" id="10.1038/384638a0"/>
</citation>
<scope>STRUCTURE BY NMR OF 218-335</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Nature" volume="457" first="1019" last="1022">
<title>The Fas-FADD death domain complex structure unravels signalling by receptor clustering.</title>
<authorList>
<person name="Scott F.L."/>
<person name="Stec B."/>
<person name="Pop C."/>
<person name="Dobaczewska M.K."/>
<person name="Lee J.J."/>
<person name="Monosov E."/>
<person name="Robinson H."/>
<person name="Salvesen G.S."/>
<person name="Schwarzenbacher R."/>
<person name="Riedl S.J."/>
</authorList>
<dbReference type="PubMed" id="19118384"/>
<dbReference type="DOI" id="10.1038/nature07606"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.73 ANGSTROMS) OF 223-335 IN COMPLEX WITH FADD</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-291 AND ILE-313</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Acta Crystallogr. D" volume="70" first="1604" last="1613">
<title>Structural insights into the mechanism of calmodulin binding to death receptors.</title>
<authorList>
<person name="Jiang T."/>
<person name="Cao P."/>
<person name="Gong Y."/>
<person name="Yu H.J."/>
<person name="Gui W.J."/>
<person name="Zhang W.T."/>
</authorList>
<dbReference type="PubMed" id="24914971"/>
<dbReference type="DOI" id="10.1107/S1399004714006919"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 230-254 IN COMPLEX WITH CALM</scope>
<scope>CALMODULIN-BINDING</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="Cell" volume="81" first="935" last="946">
<title>Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.</title>
<authorList>
<person name="Fisher G.H."/>
<person name="Rosenberg F.J."/>
<person name="Straus S.E."/>
<person name="Dale J.K."/>
<person name="Middleton L.A."/>
<person name="Lin A.Y."/>
<person name="Strober W."/>
<person name="Lenardo M.J."/>
<person name="Puck J.M."/>
</authorList>
<dbReference type="PubMed" id="7540117"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90013-6"/>
</citation>
<scope>VARIANT ALPS1A PRO-241</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="N. Engl. J. Med." volume="335" first="1643" last="1649">
<title>Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.</title>
<authorList>
<person name="Drappa J."/>
<person name="Vaishnaw A.K."/>
<person name="Sullivan K.E."/>
<person name="Chu J.-L."/>
<person name="Elkon K.B."/>
</authorList>
<dbReference type="PubMed" id="8929361"/>
<dbReference type="DOI" id="10.1056/NEJM199611283352204"/>
</citation>
<scope>VARIANT ALPS1A TYR-260</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Blood" volume="89" first="902" last="909">
<title>Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.</title>
<authorList>
<person name="Bettinardi A."/>
<person name="Brugnoni D."/>
<person name="Quiros-Roldan E."/>
<person name="Malagoli A."/>
<person name="La Grutta S."/>
<person name="Correra A."/>
<person name="Notarangelo L.D."/>
</authorList>
<dbReference type="PubMed" id="9028321"/>
</citation>
<scope>VARIANTS ALPS1A TRP-121 AND CYS-232</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1997" name="Blood" volume="89" first="1341" last="1348">
<title>Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.</title>
<authorList>
<person name="Sneller M.C."/>
<person name="Wang J."/>
<person name="Dale J.K."/>
<person name="Strober W."/>
<person name="Middelton L.A."/>
<person name="Choi Y."/>
<person name="Fleisher T.A."/>
<person name="Lim M.S."/>
<person name="Jaffe E.S."/>
<person name="Puck J.M."/>
<person name="Lenardo M.J."/>
<person name="Straus S.E."/>
</authorList>
<dbReference type="PubMed" id="9028957"/>
</citation>
<scope>VARIANTS ALPS1A ASP-257 AND SER-310</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1997" name="Gastroenterology" volume="113" first="1384" last="1389">
<title>Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.</title>
<authorList>
<person name="Pensati L."/>
<person name="Costanzo A."/>
<person name="Ianni A."/>
<person name="Accapezzato D."/>
<person name="Iorio R."/>
<person name="Natoli G."/>
<person name="Nisini R."/>
<person name="Almerighi C."/>
<person name="Balsano C."/>
<person name="Vajro P."/>
<person name="Vegnente A."/>
<person name="Levrero M."/>
</authorList>
<dbReference type="PubMed" id="9322534"/>
<dbReference type="DOI" id="10.1053/gast.1997.v113.pm9322534"/>
</citation>
<scope>VARIANT ALPS1A ALA-28</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1998" name="Blood" volume="92" first="3018" last="3024">
<title>Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.</title>
<authorList>
<person name="Groenbaek K."/>
<person name="Straten P.T."/>
<person name="Ralfkiaer E."/>
<person name="Ahrenkiel V."/>
<person name="Andersen M.K."/>
<person name="Hansen N.E."/>
<person name="Zeuthen J."/>
<person name="Hou-Jensen K."/>
<person name="Guldberg P."/>
</authorList>
<dbReference type="PubMed" id="9787134"/>
</citation>
<scope>VARIANTS NON-HODGKIN LYMPHOMA THR-25; PHE-180; LEU-183; ILE-198; VAL-260; LYS-264; LYS-272; PHE-278 AND ASN-299</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1998" name="J. Pediatr." volume="133" first="629" last="633">
<title>The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.</title>
<authorList>
<person name="Infante A.J."/>
<person name="Britton H.A."/>
<person name="DeNapoli T."/>
<person name="Middelton L.A."/>
<person name="Lenardo M.J."/>
<person name="Jackson C.E."/>
<person name="Wang J."/>
<person name="Fleisher T."/>
<person name="Straus S.E."/>
<person name="Puck J.M."/>
</authorList>
<dbReference type="PubMed" id="9821419"/>
<dbReference type="DOI" id="10.1016/S0022-3476(98)70102-7"/>
</citation>
<scope>VARIANT ALPS1A VAL-260</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="1002" last="1014">
<title>Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.</title>
<authorList>
<person name="Jackson C.E."/>
<person name="Fischer R.E."/>
<person name="Hsu A.P."/>
<person name="Anderson S.M."/>
<person name="Choi Y."/>
<person name="Wang J."/>
<person name="Dale J.K."/>
<person name="Fleisher T.A."/>
<person name="Middelton L.A."/>
<person name="Sneller M.C."/>
<person name="Lenardo M.J."/>
<person name="Straus S.E."/>
<person name="Puck J.M."/>
</authorList>
<dbReference type="PubMed" id="10090885"/>
<dbReference type="DOI" id="10.1086/302333"/>
</citation>
<scope>VARIANTS ALPS1A LYS-241 AND GLN-250</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1999" name="Blood" volume="94" first="2575" last="2582">
<title>Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.</title>
<authorList>
<person name="Rieux-Laucat F."/>
<person name="Blachere S."/>
<person name="Danielan S."/>
<person name="De Villartay J.P."/>
<person name="Oleastro M."/>
<person name="Solary E."/>
<person name="Bader-Meunier B."/>
<person name="Arkwright P."/>
<person name="Pondare C."/>
<person name="Bernaudin F."/>
<person name="Chapel H."/>
<person name="Nielsen S."/>
<person name="Berrah M."/>
<person name="Fischer A."/>
<person name="Le Deist F."/>
</authorList>
<dbReference type="PubMed" id="10515860"/>
</citation>
<scope>VARIANTS ALPS1A LEU-249; PRO-250; ASP-253; SER-253; ARG-259; LYS-270 AND LYS-272</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1999" name="Exp. Hematol." volume="27" first="868" last="874">
<title>Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.</title>
<authorList>
<person name="Peters A.M."/>
<person name="Kohfink B."/>
<person name="Martin H."/>
<person name="Griesinger F."/>
<person name="Wormann B."/>
<person name="Gahr M."/>
<person name="Roesler J."/>
</authorList>
<dbReference type="PubMed" id="10340403"/>
<dbReference type="DOI" id="10.1016/S0301-472X(99)00033-8"/>
</citation>
<scope>VARIANT ALPS1A GLY-272</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1999" name="J. Clin. Invest." volume="103" first="355" last="363">
<title>The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.</title>
<authorList>
<person name="Vaishnaw A.K."/>
<person name="Orlinick J.R."/>
<person name="Chu J.-L."/>
<person name="Krammer P.H."/>
<person name="Chao M.V."/>
<person name="Elkon K.B."/>
</authorList>
<dbReference type="PubMed" id="9927496"/>
<dbReference type="DOI" id="10.1172/JCI5121"/>
</citation>
<scope>VARIANTS ALPS1A ARG-82; PRO-250; GLY-260 AND ILE-270</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="J. Invest. Dermatol." volume="114" first="122" last="126">
<title>Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar.</title>
<authorList>
<person name="Lee S.H."/>
<person name="Shin M.S."/>
<person name="Kim H.S."/>
<person name="Park W.S."/>
<person name="Kim S.Y."/>
<person name="Jang J.J."/>
<person name="Rhim K.J."/>
<person name="Jang J."/>
<person name="Lee H.K."/>
<person name="Park J.Y."/>
<person name="Oh R.R."/>
<person name="Han S.Y."/>
<person name="Lee J.H."/>
<person name="Lee J.Y."/>
<person name="Yoo N.J."/>
</authorList>
<dbReference type="PubMed" id="10620127"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.2000.00819.x"/>
</citation>
<scope>VARIANTS SQUAMOUS CELL CARCINOMA SER-118; ARG-178 AND ASP-255</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2001" name="Blood" volume="98" first="194" last="200">
<title>The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.</title>
<authorList>
<person name="Straus S.E."/>
<person name="Jaffe E.S."/>
<person name="Puck J.M."/>
<person name="Dale J.K."/>
<person name="Elkon K.B."/>
<person name="Roesen-Wolff A."/>
<person name="Peters A.M.J."/>
<person name="Sneller M.C."/>
<person name="Hallahan C.W."/>
<person name="Wang J."/>
<person name="Fischer R.E."/>
<person name="Jackson C.M."/>
<person name="Lin A.Y."/>
<person name="Baeumler C."/>
<person name="Siegert E."/>
<person name="Marx A."/>
<person name="Vaishnaw A.K."/>
<person name="Grodzicky T."/>
<person name="Fleisher T.A."/>
<person name="Lenardo M.J."/>
</authorList>
<dbReference type="PubMed" id="11418480"/>
<dbReference type="DOI" id="10.1182/blood.V98.1.194"/>
</citation>
<scope>VARIANTS ALPS1A PRO-241; VAL-260; ILE-270 AND GLY-272</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1324" last="1329">
<title>The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations.</title>
<authorList>
<person name="Wang L."/>
<person name="Yang J.K."/>
<person name="Kabaleeswaran V."/>
<person name="Rice A.J."/>
<person name="Cruz A.C."/>
<person name="Park A.Y."/>
<person name="Yin Q."/>
<person name="Damko E."/>
<person name="Jang S.B."/>
<person name="Raunser S."/>
<person name="Robinson C.V."/>
<person name="Siegel R.M."/>
<person name="Walz T."/>
<person name="Wu H."/>
</authorList>
<dbReference type="PubMed" id="20935634"/>
<dbReference type="DOI" id="10.1038/nsmb.1920"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ALPS1A CYS-232; GLN-250; ASP-257; TYR-260; VAL-260; LYS-270 AND LYS-272</scope>
<scope>MUTAGENESIS OF ARG-250; GLU-261; GLN-283 AND LYS-287</scope>
</reference>
<comment type="function">
<text evidence="23 29">Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro).</text>
</comment>
<comment type="subunit">
<text evidence="10 17 18 21 23 26 28 30">Binds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD (By similarity). Binds RIPK1 and FAIM2 (PubMed:7538908, PubMed:10535980). Interacts with BABAM2 and FEM1B (PubMed:10542291, PubMed:15465831). Interacts with FADD (PubMed:21109225, PubMed:19118384). Interacts directly (via DED domain) with NOL3 (via CARD domain); inhibits death-inducing signaling complex (DISC) assembly by inhibiting the increase in FAS-FADD binding induced by FAS activation (By similarity). Interacts with CALM (PubMed:24914971).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-494743"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-397435">
<id>P62158</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-78060">
<id>Q14790</id>
<label>CASP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-603614">
<id>Q03135</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-495538">
<id>P48023</id>
<label>FASLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-476263">
<id>Q99683</id>
<label>MAP3K5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-309164">
<id>P12815</id>
<label>Pdcd6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-295890">
<id>P29590</id>
<label>PML</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-867256">
<id>Q15156</id>
<label>PML-RAR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-355227">
<id>Q12923</id>
<label>PTPN13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-494743"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15749113"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 6</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P25445-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P25445-2</id>
<name>2</name>
<name>del2</name>
<name>D</name>
<sequence type="described" ref="VSP_006481 VSP_006482"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P25445-3</id>
<name>3</name>
<name>del3</name>
<name>E</name>
<sequence type="described" ref="VSP_006483 VSP_006484"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P25445-4</id>
<name>4</name>
<name>B</name>
<sequence type="described" ref="VSP_006485 VSP_006486"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P25445-5</id>
<name>5</name>
<name>C</name>
<sequence type="described" ref="VSP_006487 VSP_006488"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P25445-6</id>
<name>6</name>
<name>TMdel</name>
<name>A</name>
<sequence type="described" ref="VSP_006489"/>
</isoform>
<isoform>
<id>P25445-7</id>
<name>7</name>
<name>FasExo8Del</name>
<sequence type="described" ref="VSP_045235 VSP_045236"/>
<text>Dominant negative isoform, resistant to Fas-mediated apoptosis.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="32">Isoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6.</text>
</comment>
<comment type="domain">
<text>Contains a death domain involved in the binding of FADD, and maybe to other cytosolic adapter proteins.</text>
</comment>
<comment type="PTM">
<text evidence="24 27">N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans.</text>
</comment>
<comment type="disease" evidence="14 15 16 20 22 25 31 33 34 35 36 38 39">
<disease id="DI-00155">
<name>Autoimmune lymphoproliferative syndrome 1A</name>
<acronym>ALPS1A</acronym>
<description>A disorder of apoptosis that manifests in early childhood and results in the accumulation of autoreactive lymphocytes. It is characterized by non-malignant lymphadenopathy with hepatosplenomegaly, and autoimmune hemolytic anemia, thrombocytopenia and neutropenia.</description>
<dbReference type="MIM" id="601859"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Autoimmune Lymphoproliferative Syndrome Database (ALPSbase)">
<link uri="https://www.niaid.nih.gov/diseases-conditions/autoimmune-lymphoproliferative-syndrome-alps"/>
<text>Mutations in TNFRSF6 causing ALPS type Ia</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tnfrsf6/"/>
</comment>
<dbReference type="EMBL" id="M67454">
<property type="protein sequence ID" value="AAA63174.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X63717">
<property type="protein sequence ID" value="CAA45250.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83490">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83491">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83492">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83493">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47993">
<property type="protein sequence ID" value="CAA88031.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47994">
<property type="protein sequence ID" value="CAA88032.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z47995">
<property type="protein sequence ID" value="CAA88033.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z66556">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z70519">
<property type="protein sequence ID" value="CAA94430.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z70520">
<property type="protein sequence ID" value="CAA94431.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY495076">
<property type="protein sequence ID" value="AAS76663.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X89101">
<property type="protein sequence ID" value="CAA61473.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FM246458">
<property type="protein sequence ID" value="CAR92543.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290978">
<property type="protein sequence ID" value="BAF83667.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY450925">
<property type="protein sequence ID" value="AAR08906.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL157394">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW50151.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012479">
<property type="protein sequence ID" value="AAH12479.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7393.1">
<molecule id="P25445-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7394.1">
<molecule id="P25445-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7395.1">
<molecule id="P25445-7"/>
</dbReference>
<dbReference type="PIR" id="A40036">
<property type="entry name" value="A40036"/>
</dbReference>
<dbReference type="PIR" id="I37383">
<property type="entry name" value="I37383"/>
</dbReference>
<dbReference type="PIR" id="I37384">
<property type="entry name" value="I37384"/>
</dbReference>
<dbReference type="PIR" id="S58662">
<property type="entry name" value="S58662"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000034.1">
<molecule id="P25445-1"/>
<property type="nucleotide sequence ID" value="NM_000043.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307548.1">
<property type="nucleotide sequence ID" value="NM_001320619.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_690610.1">
<molecule id="P25445-6"/>
<property type="nucleotide sequence ID" value="NM_152871.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_690611.1">
<molecule id="P25445-7"/>
<property type="nucleotide sequence ID" value="NM_152872.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.244139"/>
<dbReference type="UniGene" id="Hs.667309"/>
<dbReference type="PDB" id="1BZI">
<property type="method" value="Model"/>
<property type="chains" value="A=1-335"/>
</dbReference>
<dbReference type="PDB" id="1DDF">
<property type="method" value="NMR"/>
<property type="chains" value="A=218-335"/>
</dbReference>
<dbReference type="PDB" id="2NA7">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C=171-198"/>
</dbReference>
<dbReference type="PDB" id="3EWT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="E=230-254"/>
</dbReference>
<dbReference type="PDB" id="3EZQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A/C/E/G/I/K/M/O=223-335"/>
</dbReference>
<dbReference type="PDB" id="3THM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="F=17-172"/>
</dbReference>
<dbReference type="PDB" id="3TJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="F=17-172"/>
</dbReference>
<dbReference type="PDBsum" id="1BZI"/>
<dbReference type="PDBsum" id="1DDF"/>
<dbReference type="PDBsum" id="2NA7"/>
<dbReference type="PDBsum" id="3EWT"/>
<dbReference type="PDBsum" id="3EZQ"/>
<dbReference type="PDBsum" id="3THM"/>
<dbReference type="PDBsum" id="3TJE"/>
<dbReference type="ProteinModelPortal" id="P25445"/>
<dbReference type="SMR" id="P25445"/>
<dbReference type="BioGrid" id="106851">
<property type="interactions" value="107"/>
</dbReference>
<dbReference type="CORUM" id="P25445"/>
<dbReference type="DIP" id="DIP-924N"/>
<dbReference type="IntAct" id="P25445">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="MINT" id="MINT-146256"/>
<dbReference type="STRING" id="9606.ENSP00000347979"/>
<dbReference type="iPTMnet" id="P25445"/>
<dbReference type="PhosphoSitePlus" id="P25445"/>
<dbReference type="SwissPalm" id="P25445"/>
<dbReference type="UniCarbKB" id="P25445"/>
<dbReference type="BioMuta" id="FAS"/>
<dbReference type="DMDM" id="119833"/>
<dbReference type="EPD" id="P25445"/>
<dbReference type="MaxQB" id="P25445"/>
<dbReference type="PaxDb" id="P25445"/>
<dbReference type="PeptideAtlas" id="P25445"/>
<dbReference type="PRIDE" id="P25445"/>
<dbReference type="TopDownProteomics" id="P25445-7">
<molecule id="P25445-7"/>
</dbReference>
<dbReference type="DNASU" id="355"/>
<dbReference type="Ensembl" id="ENST00000355279">
<molecule id="P25445-7"/>
<property type="protein sequence ID" value="ENSP00000347426"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000355740">
<molecule id="P25445-1"/>
<property type="protein sequence ID" value="ENSP00000347979"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357339">
<molecule id="P25445-6"/>
<property type="protein sequence ID" value="ENSP00000349896"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000479522">
<molecule id="P25445-3"/>
<property type="protein sequence ID" value="ENSP00000424113"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000484444">
<molecule id="P25445-2"/>
<property type="protein sequence ID" value="ENSP00000420975"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000488877">
<molecule id="P25445-4"/>
<property type="protein sequence ID" value="ENSP00000425159"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000492756">
<molecule id="P25445-5"/>
<property type="protein sequence ID" value="ENSP00000422453"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000494410">
<molecule id="P25445-4"/>
<property type="protein sequence ID" value="ENSP00000423755"/>
<property type="gene ID" value="ENSG00000026103"/>
</dbReference>
<dbReference type="GeneID" id="355"/>
<dbReference type="KEGG" id="hsa:355"/>
<dbReference type="UCSC" id="uc001kfr.4">
<molecule id="P25445-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="355"/>
<dbReference type="DisGeNET" id="355"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000026103.19"/>
<dbReference type="GeneCards" id="FAS"/>
<dbReference type="GeneReviews" id="FAS"/>
<dbReference type="HGNC" id="HGNC:11920">
<property type="gene designation" value="FAS"/>
</dbReference>
<dbReference type="HPA" id="HPA027444"/>
<dbReference type="MalaCards" id="FAS"/>
<dbReference type="MIM" id="134637">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601859">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P25445"/>
<dbReference type="OpenTargets" id="ENSG00000026103"/>
<dbReference type="Orphanet" id="3261">
<property type="disease" value="Autoimmune lymphoproliferative syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="85408">
<property type="disease" value="Juvenile rheumatoid factor-negative polyarthritis"/>
</dbReference>
<dbReference type="Orphanet" id="85410">
<property type="disease" value="Oligoarticular juvenile arthritis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36613"/>
<dbReference type="eggNOG" id="ENOG410J23A">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4112ADB">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111280"/>
<dbReference type="HOGENOM" id="HOG000139681"/>
<dbReference type="HOVERGEN" id="HBG004091"/>
<dbReference type="InParanoid" id="P25445"/>
<dbReference type="KO" id="K04390"/>
<dbReference type="OMA" id="CTTCEHG"/>
<dbReference type="OrthoDB" id="EOG091G0DU6"/>
<dbReference type="PhylomeDB" id="P25445"/>
<dbReference type="TreeFam" id="TF333916"/>
<dbReference type="Reactome" id="R-HSA-140534">
<property type="pathway name" value="Ligand-dependent caspase activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371378">
<property type="pathway name" value="Regulation by c-FLIP"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218900">
<property type="pathway name" value="CASP8 activity is inhibited"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803211">
<property type="pathway name" value="TP53 Regulates Transcription of Death Receptors and Ligands"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69416">
<property type="pathway name" value="Dimerization of procaspase-8"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75157">
<property type="pathway name" value="FasL/ CD95L signaling"/>
</dbReference>
<dbReference type="SIGNOR" id="P25445"/>
<dbReference type="EvolutionaryTrace" id="P25445"/>
<dbReference type="GeneWiki" id="Fas_receptor"/>
<dbReference type="GenomeRNAi" id="355"/>
<dbReference type="PMAP-CutDB" id="P25445"/>
<dbReference type="PRO" id="PR:P25445"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000026103"/>
<dbReference type="CleanEx" id="HS_FAS"/>
<dbReference type="ExpressionAtlas" id="P25445">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P25445">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031265">
<property type="term" value="C:CD95 death-inducing signaling complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031264">
<property type="term" value="C:death-inducing signaling complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043120">
<property type="term" value="F:tumor necrosis factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005031">
<property type="term" value="F:tumor necrosis factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097296">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034198">
<property type="term" value="P:cellular response to amino acid starvation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071455">
<property type="term" value="P:cellular response to hyperoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036337">
<property type="term" value="P:Fas signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001235">
<property type="term" value="P:positive regulation of apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:2001269">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902041">
<property type="term" value="P:regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032872">
<property type="term" value="P:regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="CDD" id="cd08316">
<property type="entry name" value="Death_FAS_TNFRSF6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd10579">
<property type="entry name" value="TNFRSF6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008063">
<property type="entry name" value="Fas_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001368">
<property type="entry name" value="TNFR/NGFR_Cys_rich_reg"/>
</dbReference>
<dbReference type="InterPro" id="IPR033998">
<property type="entry name" value="TNFRSF6_death"/>
</dbReference>
<dbReference type="InterPro" id="IPR033999">
<property type="entry name" value="TNFRSF6_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23097:SF114">
<property type="entry name" value="PTHR23097:SF114"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00020">
<property type="entry name" value="TNFR_c6"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR01680">
<property type="entry name" value="TNFACTORR6"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00208">
<property type="entry name" value="TNFR"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50017">
<property type="entry name" value="DEATH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00652">
<property type="entry name" value="TNFR_NGFR_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50050">
<property type="entry name" value="TNFR_NGFR_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0112">Calmodulin-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="11">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Tumor necrosis factor receptor superfamily member 6" id="PRO_0000034563">
<location>
<begin position="26"/>
<end position="335"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="11">
<location>
<begin position="26"/>
<end position="173"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="11">
<location>
<begin position="174"/>
<end position="190"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="11">
<location>
<begin position="191"/>
<end position="335"/>
</location>
</feature>
<feature type="repeat" description="TNFR-Cys 1">
<location>
<begin position="47"/>
<end position="83"/>
</location>
</feature>
<feature type="repeat" description="TNFR-Cys 2">
<location>
<begin position="84"/>
<end position="127"/>
</location>
</feature>
<feature type="repeat" description="TNFR-Cys 3">
<location>
<begin position="128"/>
<end position="166"/>
</location>
</feature>
<feature type="domain" description="Death" evidence="12">
<location>
<begin position="230"/>
<end position="314"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HIPK3" evidence="8">
<location>
<begin position="212"/>
<end position="317"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CALM" evidence="28">
<location>
<begin position="230"/>
<end position="254"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="209"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="225"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="27">
<location>
<position position="28"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="24">
<location>
<position position="118"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="136"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="59"/>
<end position="73"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="63"/>
<end position="82"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="85"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="104"/>
<end position="119"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="107"/>
<end position="127"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="129"/>
<end position="143"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="146"/>
<end position="157"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="149"/>
<end position="165"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006481" evidence="41 42">
<original>GERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRR</original>
<variation>DVNMESSRNAHSPATPSAKRKDPDLTWGGFVFFFCQFH</variation>
<location>
<begin position="66"/>
<end position="103"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_006483" evidence="41 42">
<original>GERKARDCTVNGDEPDCVPCQ</original>
<variation>DVNMESSRNAHSPATPSAKRK</variation>
<location>
<begin position="66"/>
<end position="86"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_006484" evidence="41 42">
<location>
<begin position="87"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006482" evidence="41 42">
<location>
<begin position="104"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_006485" evidence="42 44">
<original>GLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKC</original>
<variation>DVNMESSRNAHSPATPSAKRKDPDLTWGGFVFFFCQFH</variation>
<location>
<begin position="112"/>
<end position="149"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_006487" evidence="44 45">
<original>GLEVEINCTRTQNTKCRCKPN</original>
<variation>DVNMESSRNAHSPATPSAKRK</variation>
<location>
<begin position="112"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_006488" evidence="44 45">
<location>
<begin position="133"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_006486" evidence="42 44">
<location>
<begin position="150"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_006489" evidence="41 42">
<location>
<begin position="169"/>
<end position="189"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_045235" evidence="43">
<original>ETV</original>
<variation>MLT</variation>
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_045236" evidence="43">
<location>
<begin position="221"/>
<end position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3218619." id="VAR_020008" evidence="40">
<original>A</original>
<variation>T</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation; dbSNP:rs606231364." id="VAR_013416" evidence="37">
<original>A</original>
<variation>T</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; associated with autoimmune hepatitis type 2." id="VAR_013417" evidence="36">
<original>T</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_013418" evidence="39">
<original>C</original>
<variation>R</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In squamous cell carcinoma; burn-scar related; somatic mutation; dbSNP:rs121913083." id="VAR_018321" evidence="19">
<original>N</original>
<variation>S</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; dbSNP:rs121913078." id="VAR_013419" evidence="34">
<original>R</original>
<variation>W</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3218614." id="VAR_020009" evidence="40">
<original>T</original>
<variation>I</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In squamous cell carcinoma; burn-scar related; somatic mutation; dbSNP:rs121913084." id="VAR_018322" evidence="19">
<original>C</original>
<variation>R</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation." id="VAR_013420" evidence="37">
<original>L</original>
<variation>F</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation; dbSNP:rs758835365." id="VAR_013421" evidence="37">
<original>P</original>
<variation>L</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28362322." id="VAR_052347">
<original>I</original>
<variation>V</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation." id="VAR_013422" evidence="37">
<original>T</original>
<variation>I</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; no effect on interaction with FADD; dbSNP:rs121913079." id="VAR_013423" evidence="25 34">
<original>Y</original>
<variation>C</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; dbSNP:rs201072885." id="VAR_013424" evidence="14">
<original>T</original>
<variation>K</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; dbSNP:rs121913076." id="VAR_013425" evidence="20 31">
<original>T</original>
<variation>P</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_065128" evidence="16">
<original>V</original>
<variation>L</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; dbSNP:rs121913080." id="VAR_013426" evidence="16 39">
<original>R</original>
<variation>P</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; no effect on interaction with FADD." id="VAR_013427" evidence="14 25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_065129" evidence="16">
<original>G</original>
<variation>D</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_065130" evidence="16">
<original>G</original>
<variation>S</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In squamous cell carcinoma; burn-scar related; somatic mutation; dbSNP:rs121913082." id="VAR_018323" evidence="19">
<original>N</original>
<variation>D</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; loss of interaction with FADD." id="VAR_013428" evidence="25 35">
<original>A</original>
<variation>D</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_065131" evidence="16">
<original>I</original>
<variation>R</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_013429" evidence="39">
<original>D</original>
<variation>G</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; also found in non-Hodgkin lymphoma; somatic mutation; loss of interaction with FADD; dbSNP:rs28929498." id="VAR_013431" evidence="20 25 37 38">
<original>D</original>
<variation>V</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; loss of interaction with FADD; dbSNP:rs121913086." id="VAR_013430" evidence="25 33">
<original>D</original>
<variation>Y</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_058910" evidence="22">
<original>I</original>
<variation>S</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation." id="VAR_013432" evidence="37">
<original>N</original>
<variation>K</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; dbSNP:rs121913081." id="VAR_013433" evidence="20 39">
<original>T</original>
<variation>I</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; loss of interaction with FADD." id="VAR_065132" evidence="16 25">
<original>T</original>
<variation>K</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_013434" evidence="15 20">
<original>E</original>
<variation>G</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A; also found in non-Hodgkin lymphoma; somatic mutation; loss of interaction with FADD." id="VAR_013435" evidence="16 25 37">
<original>E</original>
<variation>K</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation." id="VAR_013436" evidence="37">
<original>L</original>
<variation>F</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In non-Hodgkin lymphoma; somatic mutation." id="VAR_013437" evidence="37">
<original>K</original>
<variation>N</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3218611." id="VAR_020942" evidence="40">
<original>T</original>
<variation>I</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1A." id="VAR_013438" evidence="35">
<original>I</original>
<variation>S</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased interaction with FADD." evidence="25">
<original>R</original>
<variation>E</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FADD." evidence="25">
<original>E</original>
<variation>K</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FADD." evidence="25">
<original>Q</original>
<variation>K</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased interaction with FADD." evidence="25">
<original>K</original>
<variation>D</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with FADD." evidence="23">
<original>Y</original>
<variation>D</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive activation. Promotes apoptosis, both in the presence and in the absence of stimulation by a ligand." evidence="23">
<original>I</original>
<variation>D</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AAR08906." ref="11" evidence="46">
<original>L</original>
<variation>F</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; CAR92543." ref="9" evidence="46">
<original>L</original>
<variation>P</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="87"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="113"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="126"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="174"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="184"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="232"/>
<end position="242"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="256"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="270"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="287"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="327"/>
<end position="334"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DDF"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2NA7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EWT"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EZQ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3TJE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P25446"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63199"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00064"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00206"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10090885"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10340403"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10515860"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10535980"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10542291"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10620127"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11418480"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15465831"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17336828"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19118384"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20935634"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21109225"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22171320"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24914971"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7533181"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7538908"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7540117"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7575433"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8929361"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9028321"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9028957"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9322534"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9787134"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9821419"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9927496"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7533181"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7575433"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8598453"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8648105"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source ref="8"/>
</evidence>
<evidence key="46" type="ECO:0000305"/>
<sequence length="335" mass="37732" checksum="0139942535111410" modified="1992-05-01" version="1" precursor="true">
MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCH
KPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCT
RTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLL
LLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVM
TLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKK
ANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>